172 related articles for article (PubMed ID: 38798589)
21. Peer support in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): a qualitative study.
Amonoo HL; Harnedy LE; Deary EC; Traeger L; Brown LA; Daskalakis EP; Cutler C; Kelkar AH; Rosales R; Goldschen L; Pirl WF; Feig EH; Revette A; Lee SJ; Huffman JC; El-Jawahri A
Bone Marrow Transplant; 2022 Aug; 57(8):1277-1286. PubMed ID: 35589998
[TBL] [Abstract][Full Text] [Related]
22. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.
Castagnoli R; Delmonte OM; Calzoni E; Notarangelo LD
Front Pediatr; 2019; 7():295. PubMed ID: 31440487
[TBL] [Abstract][Full Text] [Related]
24. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
25. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Gavriilaki E; Bousiou Z; Batsis I; Vardi A; Mallouri D; Koravou EE; Konstantinidou G; Spyridis N; Karavalakis G; Noli F; Patriarcheas V; Masmanidou M; Touloumenidou T; Papalexandri A; Poziopoulos C; Yannaki E; Sakellari I; Politou M; Papassotiriou I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203404
[TBL] [Abstract][Full Text] [Related]
26. Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation.
Michniacki TF; Choi SW; Peltier DC
Handb Exp Pharmacol; 2022; 272():209-243. PubMed ID: 34628553
[TBL] [Abstract][Full Text] [Related]
27. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002.
Kasow KA; King E; Rochester R; Tong X; Srivastava DK; Horwitz EM; Leung W; Woodard P; Handgretinger R; Hale GA
Biol Blood Marrow Transplant; 2007 Jul; 13(7):831-7. PubMed ID: 17580261
[TBL] [Abstract][Full Text] [Related]
29. Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
Seo E; Choi ES; Kim JH; Kim H; Koh KN; Im HJ; Lee J
PLoS One; 2021; 16(2):e0246191. PubMed ID: 33544726
[TBL] [Abstract][Full Text] [Related]
30. Enumeration of bone marrow plasmacytoid dendritic cells by multiparameter flow cytometry as a prognostic marker following allogeneic hematopoietic stem cell transplantation.
Su RJ; Green R; Chen M
Blood Cells Mol Dis; 2018 Mar; 69():107-112. PubMed ID: 29137845
[TBL] [Abstract][Full Text] [Related]
31. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
32. Nuances in the interpretation and utility of donor-derived cell-free DNA in lung transplantation following allogeneic hematopoietic stem cell transplantation - Case report.
Manickavel S; Glehn-Ponsirenas R; Gray J; Furuya Y; Fu D; Gulbahce N; Woodward R; Kaneku H; Castillo-Fernandez J; Salgado J; Pelaez A; Pipkin M; Machuca T; Sinha N
Transpl Immunol; 2024 Jun; 84():102055. PubMed ID: 38744349
[TBL] [Abstract][Full Text] [Related]
33. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
Front Immunol; 2020; 11():668. PubMed ID: 32431694
[TBL] [Abstract][Full Text] [Related]
34. Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
Mahadeo KM; Baiocchi R; Beitinjaneh A; Chaganti S; Choquet S; Dierickx D; Dinavahi R; Duan X; Gamelin L; Ghobadi A; Guzman-Becerra N; Joshi M; Mehta A; Navarro WH; Nikiforow S; O'Reilly RJ; Reshef R; Ruiz F; Spindler T; Prockop S
Lancet Oncol; 2024 Mar; 25(3):376-387. PubMed ID: 38309282
[TBL] [Abstract][Full Text] [Related]
35. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
Wetzel L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
[TBL] [Abstract][Full Text] [Related]
36. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
37. Characterizing the cutaneous late effects of allogeneic hematopoietic stem cell transplantation: A systematic review.
Bourkas AN; Sibbald C; Chan AW; Schechter T; Ali M; Pullattayil AK; Levy R
Pediatr Transplant; 2024 Feb; 28(1):e14618. PubMed ID: 37786978
[TBL] [Abstract][Full Text] [Related]
38. A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation.
Paul DS; Jones A; Sellar RS; Mayor NP; Feber A; Webster AP; Afonso N; Sergeant R; Szydlo RM; Apperley JF; Widschwendter M; Mackinnon S; Marsh SG; Madrigal JA; Rakyan VK; Peggs KS; Beck S
Genome Med; 2015 Dec; 7():128. PubMed ID: 26669438
[TBL] [Abstract][Full Text] [Related]
39. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
[TBL] [Abstract][Full Text] [Related]
40. Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint.
Solh M; Zhang X; Connor K; Brown S; Morris LE; Holland HK; Bashey A; Solomon SR
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2192-2198. PubMed ID: 28864140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
